+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Back Pain Drug"

Chronic Lower Back Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Lower Back Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chronic Lower Back Pain (CLBP) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Chronic Lower Back Pain (CLBP) - Epidemiology Forecast - 2034

  • Report
  • April 2024
  • 146 Pages
  • Global
From
Chronic Lower Back Pain Global Market Report 2024 - Product Thumbnail Image

Chronic Lower Back Pain Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Chronic Back Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Back Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Low Back Pain - Pipeline Review, H2 2020 - Product Thumbnail Image

Low Back Pain - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 138 Pages
  • Global
From
From
From
From
  • 9 Results (Page 1 of 1)
Loading Indicator

The Back Pain Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. These drugs are used to treat a variety of conditions, including lower back pain, neck pain, and osteoarthritis. Commonly prescribed medications include non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and opioids. In addition, physical therapy, exercise, and lifestyle modifications are often recommended to help manage pain. The Back Pain Drug market is highly competitive, with a variety of companies offering products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., Novartis, and Johnson & Johnson. Other companies include Eli Lilly, Sanofi, AstraZeneca, and AbbVie. Show Less Read more